References
- NOLAND, LUDVIK B, BEERDSEN P, JOYCE M, OLEFSKY J: Improvement in glucose tolerance and insulin resis-tance in obese subjects treated with troglitazone. New Engl. J. Med. (1994) 331:1188–1193.
- NOLAN JJ, LUDVIK B, BEERDSEN P, JOYCE M: Metabolic effects of troglitazone in subjects with impaired glucose tolerance and insulin resistance. Diabetes (1994) 43\(Suppl. 1):A154.
- IWAMOTO Y, KUZUYA T, MATSUDA A: Effects of new antidlabetic agent CS-045 on glucose tolerance and Insulin secretion in patients with NIDDM. Diabetes Care (1991) 14:1083–1086.
- SUTTER SL, NOLAND, WALLACE P, GUMBINER B, OLEFSKYJM: Metabolic effects of a new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care (1992) 15:193–203.
- KANEKO T, KAKU K, KOSAKA K, SHIMIZU N, KUZUYA T, AKANUM Y: A multi-center double-blind placebo-con-trolled study of the efficacy and safety of a new oral hypoglycemic agent CS-045 in the treatment of NIDDM. Diabetes (1993) 42\(Suppl. 1):A58.
- AICANUMA Y, KOSAKA K, KUZUYA T, SHIGETA Y, KANEKO T: Clinical evaluation of a new oral hypogly-cemic agent CS-045 in NIDDM. Diabetologia (1993) 36\(Suppl. 1):A182.
- ONUMA T, TSUTSUI M, GOTO T, BOKU A, TAICEBE K: The effect of a new oral hypoglycemic drug, CS-045, on glucose tolerance and serum lipids in nonobese Japa-nese patients with non-insulin-dependent diabetes mellitus: A pilot study. Curr. Tiger. Res. (1994) 55:416–421.
- HOFMANN CA, COLCA JR: New oral thiazolidinedione antidialbetic agents act as insulin sensitizers. Diabetes Care (1992) 15:1075–1078.
- ANTONUCCI T, NORRIS R, MCCLAIN R, WHITCOMB R: An Investigator-blinded, randomized, multicenter, pla-cebo-controlled trial of the effect of troglitazone (CI-991) on impaired glucose tolerance (IGT) and insulin resistance. Diabetes (1994) 43\(Suppl. 1):A253.
- KEEN H: Insulin resistance and the prevention of dia-betes mellitus. New Engl. J. Med. (1994) 331:1226–1227.
- RUBIN RJ, ALTMAN WM, MENDELSON DN: Health careexpenditures for people with diabetes mellitus, 1992.J. Clin. Endocrinol. Metab. (1994) 78:809A–809F.
- REAVEN GM: Role of insulin resistance in human dis-ease. Diabetes (1988) 37:1595–1607.
- REAVEN GM: Role of insulin resistance in the patho-physiology of non-insulin dependent diabetes mellitus. Diabetes/Met. Rev. (1993) 9:5S–12S.
- FERRANNINI E, HAFFNER SM, MITCHELL BD, STERN MP:Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia (1991) 34:416–422.
- DUBEY RK, ZANG HY, REDDY SR, BOEGEHOLD MA, KOTCHEN TA: Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle In rats. Am. J. Physiol. (1993) 265:R726–732.
- KEMNITZ JM, ELSON DF, ROECKER EB, BAUM ST, BERGMAN RN, MEGLASSON MD: Pioglitazone increases Insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insu-lin-resistant rhesus monkeys. Diabetes (1994) 43:204–211.
- HARLAN WR, KALBERER yr, VOGEL MA: Disease preven-tion at the NM: An agenda for all. Introduction: Preven-tative Medicine (1994) 23:547–548.
- JARRETT RJ, MCCARTNEY P, KEEN H: The Bedford survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia (1982) 26:79–84.
- KADOWAKI T, MIYAKE Y, HAGURE R: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia (1984) 26:44–49.
- KNOWLER WC, PETTITT DJ, SAAD ME, BENNETT PH: Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis. Diabetes Metab. Rev. (1990) 6:1–27.
- HAFFNER SM, STERN MP, MITCHELL BD, HAZUDA HP, PATTERSON JK: Incidence of type 11 diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes (1990) 39:283–288.
- THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mel-litus. New Engl. J. Med. (1993) 329:977–986.